Johnson and Johnson wins reversal of 72 million dollars verdict over talc cancer risks Ruby Khatun Khatun18 Oct 2017 10:01 AM ISTJohnson and Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they...
Ayurveda witnesses global resurgence; Market size to touch 8 billion dollars by 2022: Shripad Ruby Khatun Khatun18 Oct 2017 9:57 AM ISTNew Delhi: Minister of State for AYUSH Shripad Yesso Naik on Monday said a threefold increase in market size of Ayurvedic products from 2.5 billion to...
Novo Nordisk diabetes drug works; no heart risk-FDA review Ruby Khatun Khatun18 Oct 2017 9:40 AM ISTNovo Nordisk A/S’s closely watched diabetes drug semaglutide is effective, caused no heart risk, and carried the only limited risk of sight problems,...
US judge in Texas invalidates Allergan patents on Restasis Ruby Khatun Khatun18 Oct 2017 9:15 AM ISTA U.S. judge on Monday invalidated patents on Allergan Plc’s dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious,...
Nurses cannot Dispense Medicines: High court turns Government order Ruby Khatun Khatun17 Oct 2017 1:28 PM ISTKOCHI: Giving their decision on the petition filed by M Sabira regarding the distribution of medicines through unqualified pharmacists, Kerala High...
Glenmark gets USFDA nod for Aprepitant capsules Ruby Khatun Khatun17 Oct 2017 10:17 AM ISTNew Delhi: Glenmark Pharmaceuticals said its US-based arm has received final approval from the US FDA for Aprepitant capsules, used for preventing...
Zydus Cadila gets USFDA nod to market Allopurinol tablets Ruby Khatun Khatun17 Oct 2017 10:03 AM ISTNew Delhi: Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market Allopurinol tablets used for...
FDA clears new robotically-assisted surgical device for adult patients Ruby Khatun Khatun17 Oct 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate...
Roches Alecensa wins EU panels nod against mutated lung cancer Ruby Khatun Khatun17 Oct 2017 9:37 AM ISTZURICH: Swiss drugmaker Roche’s Alecensa has been recommended for approval in Europe as a first-line treatment for mutated lung cancer, a key European...
Regeneron, Sanofi drug succeeds mid-stage study Ruby Khatun Khatun17 Oct 2017 9:15 AM ISTRegeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the...
MSD Pharma HPV Vaccine: Supreme Court hearing on issue Ruby Khatun Khatun16 Oct 2017 5:00 PM ISTNew Delhi: The Supreme Court in the matter of the HPV vaccine approval of MSD pharmaceuticals recently commenced hearing on the issue whether it can...
Pharma companies may post better results in Q2 on local biz growth Ruby Khatun Khatun16 Oct 2017 10:31 AM ISTMumbai: Indian pharmaceutical companies are expected to post better results in the second quarter of the current fiscal, following the recovery in the...
